Toshiba Medical’s New Premium Cardiovascular Ultrasound Receives FDA Clearance

Saturday, March 18, 2017

Cardiologists can now access the advanced ultrasound imaging technology needed for fast and confident diagnoses with Toshiba Medical’s Aplio™ i900. The newly FDA-cleared system is the latest addition to the premium Aplio i-series ultrasound platform, helping to elevate cardiovascular ultrasound with excellent imaging clarity and definition.

The Aplio i900 brings ultra-premium cardiac imaging to an everyday clinical setting, offering healthcare facilities a more cost-effective, less invasive and safer solution than other radiation emitting modalities. The system boasts innovative features that allow clinicians to quickly and easily assess myocardial function or to quantify complex valvular lesions with greater depth and detail.

Ideally suited for contrast, fetal, pediatric, stress echo and transesophageal echocardiography imaging, the Aplio i900 delivers extreme processing power which helps healthcare providers see more in their ultrasound exams due to thinner beam slices and more return information in each image. A new beam-forming technology, iBeam, optimizes efficiency of the beam, increasing penetration, spatial resolution and contrast resolution. Boosting productivity during exams, the Aplio i900 provides intuitive ergonomics with iSense and touch control screens, and real-time quick scan makes automatic image adjustments without pushing a button.

“The Aplio i900 presents a real breakthrough in expanding the clinical utility of ultrasound, offering cardiologists a new tool for fast, safe and confident diagnoses even in technically difficult patient exams,” said Dan Skyba, director, Ultrasound Business Unit, Toshiba America Medical Systems, Inc. “The system combines crystal clear image quality with cutting edge clinical applications to make work flow and help clinicians provide the best possible patient care.”

Toshiba Medical is showcasing the Aplio i900 at this year’s American College of Cardiology (ACC) 2017 annual meeting in Washington, D.C., March 17–19, 2017 (Booth #1625).

TOP